This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Souta Yamasaki: Innovator in Pharmaceutical Chemistry
Introduction
Souta Yamasaki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of triazine compounds. His innovative methods have the potential to enhance the efficiency of pharmaceutical manufacturing processes.
Latest Patents
Yamasaki holds a patent for a "Method for producing triazine compound." This invention provides an industrially advantageous method for producing a 3,5-disubstituted triazine compound that serves as an active pharmaceutical ingredient. The method allows for the efficient production of a 3-oxo-5-substituted triazine in water, eliminating the need to isolate potentially mutagenic intermediates. The process includes several steps, such as reacting specific compounds in the presence of a base, which streamlines the production process.
Career Highlights
Souta Yamasaki is associated with Mitsubishi Tanabe Pharma Corporation, where he applies his expertise in pharmaceutical development. His work focuses on creating methods that improve the safety and efficiency of drug production. With 1 patent to his name, Yamasaki is recognized for his contributions to the field.
Collaborations
Yamasaki collaborates with talented colleagues, including Takafumi Yamagami and Tomofumi Setsuta. Their combined efforts contribute to advancements in pharmaceutical research and development.
Conclusion
Souta Yamasaki's innovative approach to producing triazine compounds marks a significant advancement in pharmaceutical chemistry. His work not only enhances production efficiency but also prioritizes safety in drug manufacturing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
